Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 7114 (MIR7114) is a small non-coding RNA molecule classified as a microRNA that regulates gene expression post-transcriptionally, typically by binding to target mRNA and inhibiting translation or promoting degradation. MIR7114 has been studied in the context of colorectal cancer, where it shows an inverse expression correlation with the CEACAM1 gene, suggesting a role in early tumorigenesis and potential usefulness as a molecular biomarker for colorectal cancer[1][6]. There is currently no evidence that MIR7114 itself acts as a direct therapeutic target, nor are there known drugs or clinical interventions that specifically modulate its activity. Its function and disease associations require further study for therapeutic targeting.
Not applicable (no drugs known to directly target MIR7114)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 7114 (MIR7114).